Calendrier des promotions NetraMark Holdings Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise NetraMark Holdings Inc.
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.Paramètres de base
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 27.95 | 1 |
| P/BV | -86.85 | 0 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -427.11 | 0 |
| ROE | -1020.96 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 0 | 10 |
| Debt/Ratio | 0 | 10 |
| Debt/Equity | -2.05 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 460.02 | 10 |
| Rentabilité Ebitda, % | 0 | 0 |
| Rentabilité EPS, % | 458.89 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 0.9251 $ | 0 $ | 0 $ | 1.5 % | 0 % | 0 % |
| common.calendar.number_days.7d | 0.87 $ | 0 $ | 0 $ | 7.93 % | 0 % | 0 % |
| common.calendar.number_days.30d | 1.1 $ | 0.87 $ | 1 $ | -14.33 % | 0 % | 0 % |
| common.calendar.number_days.90d | 0.9895 $ | 0.75 $ | 1.18 $ | -5.1 % | 0 % | 0 % |
| common.calendar.number_days.180d | 0.5985 $ | 0.5652 $ | 1.18 $ | 56.89 % | 0 % | 0 % |
| common.calendar.number_days.1y | 0.1768 $ | 0.114 $ | 1.18 $ | 431.11 % | 0 % | 0 % |
| common.calendar.number_days.3y | 0 $ | 0.114 $ | 1.18 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 $ | 0.114 $ | 1.18 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 0.114 $ | 1.18 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 0.801 $ | 0.5652 $ | 1.18 $ | 17.23 % | 0 % | 0 % |
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. George Achilleos | CEO & Director | ||
| Mr. Josh Spiegel | President | ||
| Mr. Daniel Gallucci | Founder, Chief Performance Officer & Director | 1977 (48 années) | |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific & Technical Officer and Director | ||
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer | 1969 (56 années) | |
| Ms. Jaime Hackett | Vice President of Marketing | ||
| Dr. Luca Pani M.D. | Chief Innovation & Regulatory Officer and Chief Medical Advisor | ||
| Dr. Kaveh Kavoosi | Head of Progressive Medicine | ||
| Dr. Larry Alphs | Chief Medical Officer & Member of Advisory Board | ||
| Mr. Mark Smithyes | President of NetraMark | 1970 (55 années) |
Informations sur l'entreprise
Adresse: Canada, Toronto, 1655 Dupont Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.netramark.com
Site web: https://www.netramark.com
